Functional O
neuroimaging O
effects O
of O
recently O
discovered O
genetic O
risk O
loci O
for O
schizophrenia O
and O
polygenic O
risk O
profile O
in O
five O
RDoC O
subdomains O
Recently O
, O
125 O
loci O
with O
genome-wide O
support O
for O
association O
with O
schizophrenia O
were O
identified O
. O

We O
investigated O
the O
impact O
of O
these O
variants O
and O
their O
accumulated O
genetic O
risk O
on O
brain O
activation O
in O
five O
neurocognitive O
domains O
of O
the O
Research O
Domain O
Criteria O
( O
working O
memory O
, O
reward O
processing O
, O
episodic O
memory O
, O
social O
cognition O
and O
emotion O
processing O
) O
. O

In O
578 O
healthy O
subjects O
we O
tested O
for O
association O
( O
i O
) O
of O
a O
polygenic O
risk O
profile O
score O
( O
RPS O
) O
including O
all O
single-nucleotide O
polymorphisms O
( O
SNPs O
) O
reaching O
genome-wide O
significance O
in O
the O
recent O
genome-wide O
association O
studies O
( O
GWAS O
) O
meta-analysis O
and O
( O
ii O
) O
of O
all O
independent O
genome-wide O
significant O
loci O
separately O
that O
showed O
sufficient O
distribution O
of O
all O
allelic O
groups O
in O
our O
sample O
( O
105 O
SNPs O
) O
. O

The O
RPS O
was O
nominally O
associated O
with O
perigenual O
anterior O
cingulate O
and O
posterior O
cingulate/precuneus O
activation O
during O
episodic O
memory O
( O
PFWE O
( O
ROI O
) O
=0.047 O
) O
and O
social O
cognition O
( O
PFWE O
( O
ROI O
) O
=0.025 O
) O
, O
respectively O
. O

Single O
SNP O
analyses O
revealed O
that O
rs9607782 O
, O
located O
near O
EP300 O
, O
was O
significantly O
associated O
with O
amygdala O
recruitment O
during O
emotion O
processing O
( O
PFWE O
( O
ROI O
) O
=1.63 O
× O
10−4 O
, O
surpassing O
Bonferroni O
correction O
for O
the O
number O
of O
SNPs O
) O
. O

Importantly O
, O
this O
association O
was O
replicable O
in O
an O
independent O
sample O
( O
N=150 O
; O
PFWE O
( O
ROI O
) O
< O
0.025 O
) O
. O

Other O
SNP O
effects O
previously O
associated O
with O
imaging O
phenotypes O
were O
nominally O
significant O
, O
but O
did O
not O
withstand O
correction O
for O
the O
number O
of O
SNPs O
tested O
. O

To O
assess O
whether O
there O
was O
true O
signal O
within O
our O
data O
, O
we O
repeated O
single O
SNP O
analyses O
with O
105 O
randomly O
chosen O
non-schizophrenia-associated O
variants O
, O
observing O
fewer O
significant O
results O
and O
lower O
association O
probabilities O
. O

Applying O
stringent O
methodological O
procedures O
, O
we O
found O
preliminary O
evidence O
for O
the O
notion O
that O
genetic O
risk O
for O
schizophrenia O
conferred O
by O
rs9607782 O
may O
be O
mediated O
by O
amygdala O
function O
. O

We O
critically O
evaluate O
the O
potential O
caveats O
of O
the O
methodological O
approaches O
employed O
and O
offer O
suggestions O
for O
future O
studies O
. O

Materials O
and O
methods O
Subjects O
A O
total O
of O
578 O
German O
volunteers O
who O
never O
suffered O
from O
psychiatric O
disorder O
( O
evidenced O
by O
SCID-I O
) O
were O
recruited O
at O
Mannheim O
, O
Berlin O
and O
Bonn O
as O
part O
of O
an O
ongoing O
study O
on O
neurogenetic O
mechanisms O
of O
unipolar O
depression O
, O
bipolar O
disorder O
and O
schizophrenia O
( O
http O
: O
//www.ngfn.de/en/ O
schizophrenie.html O
; O
http O
: O
//www.sys-med.de/en/consortia/integrament/ O
) O
. O

N=333 O
participants O
had O
no O
lifetime O
family O
history O
of O
schizophrenia O
or O
an O
affective O
disorder O
, O
and O
n=245 O
subjects O
had O
at O
least O
one O
first-degree O
relative O
affected O
by O
schizophrenia O
( O
n=72 O
) O
, O
bipolar O
disorder O
( O
n=71 O
) O
or O
depression O
( O
n=102 O
) O
. O

Affected O
index O
patients O
did O
not O
suffer O
from O
any O
other O
psychotic O
or O
affective O
disorder O
, O
and O
the O
investigated O
relatives O
had O
no O
family O
history O
of O
multiple O
different O
psychiatric O
diagnoses O
( O
for O
example O
, O
cases O
of O
both O
, O
affective O
and O
psychotic O
disorders O
) O
. O

All O
subjects O
had O
grandparents O
of O
European O
origin O
. O

Following O
application O
of O
exclusion O
criteria O
n=472–509 O
subjects O
were O
included O
in O
the O
analyses O
of O
the O
respective O
tasks O
( O
see O
Supplementary O
Material O
for O
details O
) O
. O

N=150 O
controls O
recruited O
as O
part O
of O
a O
study O
on O
the O
neurogenetic O
mechanisms O
of O
alcohol O
dependence O
in O
Berlin O
and O
Bonn O
( O
http O
: O
//www.ngfn.de/en/alkoholabh__ngigkeit.html O
) O
served O
as O
replication O
sample O
. O

All O
participants O
never O
suffered O
from O
psychiatric O
disorder O
according O
to O
the O
Structured O
Clinical O
Interview O
of O
the O
Diagnostic O
and O
Statistical O
Manual O
of O
Mental O
Disorders O
( O
DSM-IV O
) O
Axis-I O
Disorders O
( O
SCID-I O
) O
. O

Demographic O
characteristics O
of O
the O
respective O
subsamples O
are O
given O
in O
Supplementary O
Tables O
S1 O
and O
S2 O
. O

The O
study O
was O
approved O
by O
local O
ethics O
committees O
of O
the O
universities O
of O
Heidelberg O
, O
Berlin O
and O
Bonn O
. O

All O
participants O
gave O
written O
informed O
consent O
to O
the O
study O
according O
to O
the O
Declaration O
of O
Helsinki O
. O

DNA O
extraction O
and O
genotyping O
Ethylenediaminetetraacetic O
acid O
anticoagulated O
venous O
blood O
samples O
were O
collected O
from O
all O
individuals O
. O

Lymphocyte O
DNA O
was O
isolated O
using O
the O
Chemagic O
Magnetic O
Separation O
Module O
I O
( O
Chemagen O
, O
Baesweiler O
, O
Germany O
) O
according O
to O
the O
manufacturer O
’ O
s O
recommendations O
. O

A O
genome-wide O
data O
set O
was O
generated O
at O
the O
Department O
of O
Genomics O
, O
Life O
& O
Brain O
Center O
, O
University O
of O
Bonn O
using O
Illumina O
’ O
s O
Human610Quad O
, O
Human660W-Quad O
and O
Infinium O
PsychArray-24 O
BeadChips O
( O
Illumina O
, O
San O
Diego O
, O
CA O
, O
USA O
) O
. O

Quality O
control O
and O
imputation O
were O
performed O
with O
standard O
parameters O
used O
by O
the O
Psychiatric O
Genetics O
Consortium O
( O
PGC O
) O
Statistical O
Analyses O
Group O
and O
RPS O
were O
calculated O
using O
methods O
described O
by O
Purcell O
et O
al O
. O

( O
see O
Supplementary O
Material O
for O
details O
) O
. O

Functional O
imaging O
tasks O
During O
functional O
magnetic O
resonance O
imaging O
( O
fMRI O
) O
subjects O
completed O
an O
associative O
episodic O
memory O
( O
EM O
) O
task O
requiring O
encoding O
, O
recall O
and O
recognition O
of O
face-profession O
pairs O
. O

The O
WM O
n-back O
task O
required O
continuous O
updating O
and O
retrieval O
of O
elements O
held O
in O
short-time O
memory O
. O

The O
RP O
monetary O
incentive O
delay O
task O
allowed O
the O
study O
of O
anticipation O
of O
monetary O
gains O
or O
losses O
. O

The O
Theory O
of O
Mind O
( O
ToM O
) O
task O
consisted O
of O
cartoon O
stories O
requiring O
subjects O
to O
take O
the O
protagonist O
’ O
s O
perspective O
and O
judge O
changes O
in O
his/her O
affective O
states O
. O

The O
face-matching O
task O
( O
FMT O
) O
operationalized O
subjects O
’ O
implicit O
processing O
of O
negative O
emotions O
while O
viewing O
faces O
showing O
either O
fearful O
or O
angry O
expressions O
( O
for O
detailed O
descriptions O
see O
refs O
and O
Supplementary O
Material O
) O
. O

All O
tasks O
were O
previously O
shown O
to O
robustly O
activate O
target O
structures O
and O
to O
possess O
excellent O
test–retest O
reliability O
in O
between-group O
designs O
. O

Imaging O
parameters O
Blood-oxygen-level O
dependent O
fMRI O
was O
performed O
on O
three O
Siemens O
Trio O
3 O
T O
MR-Tomographs O
at O
the O
Life O
and O
Brain O
Center O
of O
the O
University O
of O
Bonn O
, O
the O
Central O
Institute O
of O
Mental O
Health O
Mannheim O
, O
and O
the O
Charité-Universitätsmedizin O
Berlin O
. O

At O
all O
sites O
, O
identical O
sequences O
and O
scanner O
protocols O
were O
employed O
( O
EM O
: O
33 O
slices O
, O
axially O
tilted O
( O
−30° O
) O
, O
slice O
thickness O
2.4 O
mm+0.6 O
mm O
gap O
, O
field O
of O
view O
( O
FOV O
) O
192 O
mm O
, O
repetition O
time O
( O
TR O
) O
1.96 O
s O
, O
echo O
time O
( O
TE O
) O
30 O
ms O
, O
flip O
angle O
80° O
, O
all O
other O
fMRI O
tasks O
: O
28 O
slices O
, O
slice O
thickness O
4 O
mm+1 O
mm O
gap O
, O
FOV O
192 O
mm O
, O
TR O
2 O
s O
, O
TE O
30 O
ms O
, O
flip O
angle O
80° O
) O
. O

Quality-control O
measurements O
were O
conducted O
at O
all O
sites O
on O
every O
day O
of O
data O
collection O
according O
to O
a O
multicenter O
quality-assurance O
protocol O
, O
revealing O
stable O
parameters O
over O
time O
. O

To O
account O
for O
any O
variance O
related O
to O
differences O
across O
sites O
, O
the O
site O
was O
used O
as O
a O
covariate O
for O
all O
statistical O
analyses O
. O

Functional O
image O
processing O
Image O
processing O
and O
statistical O
analyses O
were O
conducted O
using O
statistical O
parametric O
mapping O
methods O
as O
implemented O
in O
SPM8 O
( O
http O
: O
//www.fil.ion.ucl.ac.uk/spm/software/spm8/ O
) O
. O

Scans O
were O
subjected O
to O
a O
strict O
quality O
assessment O
before O
inclusion O
into O
further O
analyses O
. O

Following O
data-quality O
assessment O
and O
application O
of O
general O
exclusion O
criteria O
( O
see O
above O
) O
n=472–509 O
subjects O
were O
included O
in O
the O
respective O
analyses O
( O
see O
Supplementary O
Figure O
1 O
and O
Supplementary O
Methods O
for O
details O
) O
. O

During O
pre-processing O
, O
images O
were O
realigned O
to O
a O
mean O
image O
( O
movement O
parameters O
confined O
to O
< O
3 O
mm O
translation O
and O
< O
1.7° O
rotation O
between O
volumes O
) O
, O
slice-time-corrected O
, O
spatially O
normalized O
to O
a O
standard O
stereotactic O
space O
( O
a O
brain O
template O
created O
by O
the O
Montreal O
Neurological O
Institute O
) O
with O
a O
voxel O
size O
of O
3 O
× O
3 O
× O
3 O
mm O
and O
smoothed O
with O
a O
9 O
mm O
full O
width O
at O
half O
maximum O
Gaussian O
filter O
. O

A O
first-level O
fixed-effects O
model O
was O
computed O
for O
each O
participant O
and O
task O
. O

Regressors O
were O
created O
from O
the O
time O
course O
of O
the O
experimental O
conditions O
of O
interest O
per O
task O
and O
convolved O
with O
a O
canonical O
hemodynamic O
response O
function O
. O

Movement O
parameters O
, O
and O
for O
the O
ToM O
task O
also O
instructions O
and O
button O
presses O
, O
were O
included O
in O
the O
first-level O
models O
as O
covariates O
of O
no O
interest O
. O

For O
each O
subject O
, O
individual O
contrast O
images O
of O
the O
task O
effect O
( O
WM O
: O
2-back O
> O
0-back O
; O
EM O
: O
memory O
> O
control O
; O
RP O
: O
anticipation O
of O
monetary O
win/loss O
> O
anticipation O
of O
neutral O
outcomes O
; O
ToM O
: O
mentalizing O
> O
control O
; O
FMT O
: O
faces O
> O
shapes O
) O
were O
subsequently O
entered O
into O
group O
statistics O
. O

Statistical O
group O
analyses O
RPS O
: O
To O
test O
for O
genetic O
association O
with O
the O
intermediate O
phenotypes O
, O
the O
respective O
individual O
contrast O
images O
were O
analyzed O
using O
second-level O
multiple O
regression O
models O
for O
each O
task O
, O
including O
the O
RPS O
as O
regressor O
of O
interest O
, O
and O
age O
, O
sex O
, O
site O
, O
subgroup O
( O
no O
familial O
liability O
for O
psychiatric O
disorders O
, O
affected O
first-degree O
relative O
of O
patients O
with O
schizophrenia O
, O
bipolar O
disorder O
or O
depression O
) O
, O
chip O
used O
for O
genotyping O
and O
the O
first O
three O
principal O
components O
( O
derived O
from O
a O
statistically O
independent O
set O
of O
common O
SNPs O
representing O
potential O
population O
stratification O
) O
as O
nuisance O
covariates O
. O

Effects O
of O
RPS O
on O
predefined O
regions O
of O
interest O
( O
ROIs O
) O
were O
assessed O
determining O
the O
familywise O
error O
( O
FWE O
) O
-corrected O
significance O
values O
of O
the O
maximally O
activated O
voxel O
within O
each O
ROI O
using O
undirected O
tests O
. O

For O
the O
WM O
, O
EM O
and O
FMT O
tasks O
, O
ROIs O
were O
defined O
a O
priori O
using O
anatomical O
labels O
provided O
by O
the O
Wake O
Forest O
University O
Pick O
Atlas O
( O
www.fmri.wfubmc.edu/downloads O
) O
. O

These O
were O
the O
bilateral O
dorsolateral O
prefrontal O
cortex O
( O
BA46 O
and O
BA9 O
with O
subtraction O
of O
medial O
voxels O
of O
BA9 O
, O
see O
Esslinger O
et O
al O
. O

for O
details O
) O
for O
the O
WM O
task O
, O
the O
left O
and O
right O
hippocampus O
and O
perigenual O
anterior O
cingulate O
cortex O
( O
pgACC O
) O
for O
EM O
tasks O
and O
the O
bilateral O
amygdala O
, O
as O
well O
as O
the O
pgACC O
for O
the O
FMT O
( O
Supplementary O
Figure O
S2 O
) O
. O

As O
the O
AAL O
atlas O
does O
not O
provide O
anatomical O
labels O
for O
the O
ventral O
striatum O
, O
a O
spherical O
ROI O
was O
created O
for O
the O
RP O
task O
using O
a O
voxel O
located O
in O
the O
center O
of O
the O
ventral O
striatum O
( O
x=±9 O
, O
y=11 O
, O
z=−8 O
) O
surrounded O
by O
a O
sphere O
of O
10 O
mm O
. O

For O
the O
ToM O
task O
, O
four O
functional O
ROIs O
were O
created O
for O
those O
regions O
previously O
shown O
to O
be O
aberrantly O
activated O
in O
patients O
with O
schizophrenia O
( O
for O
example O
, O
Sugranyes O
et O
al O
. O

; O
Walter O
et O
al O
. O
) O

and O
to O
be O
genetically O
modulated O
. O

As O
these O
regions O
were O
not O
covered O
by O
specific O
AAL O
ROIs O
, O
masks O
for O
the O
medial O
prefrontal O
cortex O
, O
bilateral O
temporal O
parietal O
junction O
( O
TPJ O
) O
and O
posterior O
cingulate O
cortex/precuneus O
( O
PCC/Pcu O
) O
were O
created O
based O
on O
coordinates O
reported O
by O
a O
meta-analysis O
on O
brain O
areas O
involved O
in O
ToM O
using O
the O
toolbox O
TWURoi O
( O
see O
Supplementary O
Material O
for O
details O
) O
. O

Single O
SNP O
fMRI O
analyses O
Comparable O
to O
RPS O
analyses O
, O
second-level O
multiple O
regression O
models O
were O
computed O
for O
each O
SNP O
and O
each O
task O
with O
number O
of O
minor O
alleles O
as O
regressor O
of O
interest O
, O
and O
age O
, O
sex O
, O
site O
, O
subgroup O
, O
genotyping O
chip O
and O
the O
first O
three O
principal O
components O
of O
potential O
population O
stratification O
as O
nuisance O
covariates O
. O

We O
excluded O
SNPs O
with O
less O
than O
10 O
subjects O
in O
one O
allelic O
group O
, O
resulting O
in O
105 O
independent O
analyses O
. O

Similar O
to O
RPS O
analyses O
, O
we O
extracted O
FWE-corrected O
P-values O
of O
the O
maximally O
activated O
voxel O
within O
each O
ROI O
for O
each O
SNP O
from O
an O
undirected O
test O
. O

These O
significance O
values O
were O
then O
Bonferroni-corrected O
for O
the O
number O
of O
autosomal O
SNPs O
tested O
, O
that O
is O
, O
105 O
( O
P O
< O
4.76 O
× O
10−4 O
) O
. O

We O
used O
an O
undirected O
F-test O
in O
all O
analyses O
, O
as O
, O
for O
the O
investigated O
RPS O
and O
the O
vast O
majority O
of O
SNPs O
, O
we O
had O
no O
hypotheses O
about O
the O
directionality O
of O
effects O
. O

Associations O
with O
the O
intermediate O
phenotype O
could O
be O
represented O
by O
reduced O
or O
increased O
activation O
, O
being O
either O
indicative O
of O
dysfunction O
, O
inefficiency O
or O
compensatory O
resilience O
mechanisms O
. O

